Accelerate Drug Discovery with Innobodies™ Design Workflow

WHAT WE DO

We provide tailor-made AI solutions to improve the efficiency of your drug discovery and development program.

Our InnobodiesTM design workflow and small molecule discovery pipeline deliver leads within months. Our web-based optimizer optimizer.synsilico.com is minimizing experimental efforts for any optimization task, including formulation optimizations.

PHARMA
CUSTOMERS

Accelerate your drug discovery & design with AI-guided workflows.

InnobodiesTM Design

Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months.

• Microbial expression

• Humanized backbone

• Coupled gAI & M

• Sample delivery within months

Innobodies<sup>TM</sup> Design

Bayesian Optimizer

Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months.

• ultra large virtual screening

• fine tuning via molecular dynamics

Bayesian Optimizer

Small Molecule Discovery

Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months.

• simple use via web portal

• supports QbD (beyond DOE)

• versatile applications

Small Molecule Discovery

Innobodies™ Design Platform

Innobodies™
Design Platform

Wet-lab validation of hits within months

We design single-chain antibodies against your targets based on ultra-high throughput genAI tools and precise Molecular Dynamics based workflows.

Top in-silico designs are rapidly produced at lab-scale based on established microbial expression systems. After validation, the most promising hit is scaled-up to provide pilot quantites for further characterization. At this phase full-scale cost estimates can be provided to assess the economic viability of your hit.

Production strains together with protocols for fermentation and downstream processing can then be transferred to cGMP contract manufacturers of your choice.

Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months. Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months.
Unlimited diversity

GenAI surpasses all display technologies; proven humanized templates are used.

Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months. Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months.
High speed & Precision

Fast AI-driven predictions and precise MD refinement yields top candidates.

Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months. Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months.
Most economic

Microbial expression proven for economic biologics production.

Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months. Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months.
First lab validation

Top candidates quickly provided for lab validation.

Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months. Innobodies™ uses AI and MD to design, express, and validate single-chain antibodies—ready for scale-up in months.
Rapid scale-up

In-house high cell-density fermentation for gram-scale output.